drugset / Trial / NCT01136746

Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin

NCT01136746 ↗

Phase 3 Terminated 16 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the use of insulin glargine plus insulin lispro to human regular insulin for treatment of hyperglycemia in the hospital setting in patients without known prior history of diabetes.

Timeline

Start
2011-03
Primary completion
2011-11
Completion
2011-11

Outcome

Outcome not reported

Stopped (Enrollment): “Low enrollment”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic — Subcutaneous
Comparator human regular insulin Protein / enzyme biologic — Subcutaneous
Subject insulin glargine Protein / enzyme biologic — Subcutaneous

Indications